A cost-consequence analysis of the preferential use of secukinumab versus adalimumab for the treatment of psoriatic arthritis Alberto Jiménez-Morales, Rafael Cáliz, Susana Aceituno, Miriam Prades, Carles Blanch

Remission in axial spondyloarthritis: Developing a consensus definition Cristina Fernández-Carballido, Eduardo Collantes-Estévez, Jordi Gratacós, Xavier Juanola, Pedro Zarco

Disease control in patients with ankylosing spondylitis in real clinical practice in Spain: Results of the MIDAS study Eugenio de Miguel, Cristina Fernández-Carballido, Jordi Gratacós, José L. Pablos, Xavier Juanola, Rafael Ariza, Pau Terradas-Montana, Cristina Sanabra, Carlos Sastré